Concepedia

Publication | Open Access

Prognostic Value of MammaPrint<sup>®</sup> in Invasive Lobular Breast Cancer

DOIFull Paper Access

38

Citations

18

References

2016

Year

Inès J. Beumer, Marion Persoon, Anke Witteveen, Christa Dreezen, Suet‐Feung Chin, Stephen‐John Sammut, Mireille H.J. Snel, Carlos Caldas, Sabine C. Linn, Laura van ‘t Veer,
Biomarker Insights

Abstract

Study results validate MammaPrint as an independent factor for breast cancer patients with early-stage invasive lobular breast cancer. Hazard ratios up to 11 in multivariate analyses emphasize the independent value of MammaPrint, specifically in lymph node-negative ILC breast cancers.

References

YearCitations

Page 1